Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers.
Wang Y, Deng B.
Cancer Metastasis Rev. 2023 Sep;42(3):629-652. doi: 10.1007/s10555-023-10084-4. Epub 2023 Feb 2.
Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis.
Lev S.
Biochem Soc Trans. 2020 Apr 29;48(2):657-665. doi: 10.1042/BST20191055.
Targeted Therapy and Personalized Medicine.
Saeed RF, Awan UA, Saeed S, Mumtaz S, Akhtar N, Aslam S.
Cancer Treat Res. 2023;185:177-205. doi: 10.1007/978-3-031-27156-4_10.
Non-Coding RNA-Targeted Therapy: A State-of-the-Art Review.
Nappi F.
Int J Mol Sci. 2024 Mar 24;25(7):3630. doi: 10.3390/ijms25073630.
Biomarkers and targeted therapy for cancer stem cells.
Liu Y, Wang H.
Trends Pharmacol Sci. 2024 Jan;45(1):56-66. doi: 10.1016/j.tips.2023.11.006. Epub 2023 Dec 9.
Advances in targeted therapy for malignant lymphoma.
Wang L, Qin W, Huo YJ, Li X, Shi Q, Rasko JEJ, Janin A, Zhao WL.
Signal Transduct Target Ther. 2020 Mar 6;5(1):15. doi: 10.1038/s41392-020-0113-2.
Cancer treatment therapies: traditional to modern approaches to combat cancers.
Kaur R, Bhardwaj A, Gupta S.
Mol Biol Rep. 2023 Nov;50(11):9663-9676. doi: 10.1007/s11033-023-08809-3. Epub 2023 Oct 12.
RNA-Targeted Therapeutics.
Crooke ST, Witztum JL, Bennett CF, Baker BF.
Cell Metab. 2018 Apr 3;27(4):714-739. doi: 10.1016/j.cmet.2018.03.004.
Targeting AKT for cancer therapy.
Shariati M, Meric-Bernstam F.
Expert Opin Investig Drugs. 2019 Nov;28(11):977-988. doi: 10.1080/13543784.2019.1676726. Epub 2019 Oct 12.
PROTAC-Based Protein Degradation as a Promising Strategy for Targeted Therapy in Sarcomas.
Mancarella C, Morrione A, Scotlandi K.
Int J Mol Sci. 2023 Nov 15;24(22):16346. doi: 10.3390/ijms242216346.
